Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV Vaccine Uptake in Slovenian Women
NCT06995157Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by University Medical Centre Ljubljana. Primary endpoint: HPV vaccine uptake at 2 years. Started Sep 2023; status: recruiting.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT06995157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06995157.